Pathogenesis of liver fibrosis: Role of oxidative stress

Molecular Aspects of Medicine

Volumn 21, Issue 3, 2000, Pages 49-98

  Poli, Giuseppe ^a  

^a SAN LUIGI GONZAGA HOSPITAL   (Italy)

Author keywords

4 Hydroxynonenal; Cholestasis; Chronic liver diseases; Cirrhosis; Ethanol; Extracellular matrix; Fibrosis; Iron overload; Kupffer cells; Lipid peroxidation; Oxidative stress; Redox sensitive transcription factors; ROS; Stellate cells; Transforming growth factor ; Viral hepatitis

Indexed keywords

FIBROGENESIS; HUMAN; IRON OVERLOAD; KUPFFER CELL; LIVER FIBROSIS; OXIDATIVE STRESS; PATHOGENESIS; REGULATORY MECHANISM; REVIEW; VIRUS HEPATITIS;

EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; LIVER; LIVER CIRRHOSIS; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; TRANSFORMING GROWTH FACTOR BETA;

EID: 0033869778     PISSN: 00982997     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0098-2997(00)00004-2     Document Type: Review

References (252)

1. Akiyoshi H., Terada T. Centrilobular and perisinusoidal fibrosis in experimental congestive liver in the rat. J. Hepatol. 30:1999;433-439.
2. Albano, E. 2000. Free radical mechanisms of ethanol toxicity. In: Rhodes, C.J. (Ed.), Toxicology of the Human Environment. The Critical Role of Free Radicals. Taylor & Francis, London, pp. 235-263.
3. Albano E., Tomasi A., Goria-Gatti L., Dianzani M.U. Spin trapping of free radical species produced during the microsomal metabolism of ethanol. Chem-Biol. Interact. 65:1988;223-234.
4. Albano E., Clot P., Morimoto M., Tomasi A., Ingelman-Sundberg M., French S. Role of cytochrome P4502E1-dependent formation of hydroxyethyl free radicals in the development of liver damage in rats intragastrically fed with ethanol. Hepatology. 23:1996;155-163.
5. Alcolado R., Arthur M.J.P., Iredale J.P. Pathogenesis of liver fibrosis. Clin. Sci. 92:1997;103-112.
6. Angel P., Karin M. The role of June, Fos and the AP-1complex in cell-proliferation and transformation. Biochem. Biophys. Acta. 1072:1991;129-157.
7. Annoni G., Weiner F.R., Zern M.A. Increased transforming growth factor-. β 1 gene expression in human liver disease J. Hepatol. 14:1992;259-264.
8. Anscher M.S., Peters W.P., Reisenbichler H., Petros W.P., Jirtle R.L. Transforming growth factor-. β as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer New Engl. J. Med. 328:1993;1592-1598.
9. Arenson D.M., Friedman S.L., Bissell D.M. Formation of extracellular matrix in normal rat liver: lipocytes as a major source of proteoglycans. Gastroenterology. 95:1988;441-447.
10. Arrigo A.-P. Gene expression and the thiol redox state. Free Radic. Biol. Med. 27:1999;936-944.
11. Arthur M.J.P. Collagenases and liver fibrosis. J. Hepatol. 22(suppl. 2):1995;43-48.
12. Arthur M.J.P. Fibrosis and altered matrix degradation. Digestion. 59:1998;376-380.
13. Arthur M.J.P., Stanley A., Iredale J.P., Rafferty J.A., Hembry R.M., Friedman S.L. Secretion of 72-kDa type IV collagenase/gelatinase by cultured human lypocytes: Analysis of gene expression protein synthesis and proteinase activity. Biochem. J. 287:1992;701-707.
14. Armendariz-Borunda J., Simkevich C.P., Roy N., Raghow R., Kang A.H., Seyer J.M. Activation of Ito cells involves regulation of AP-1 binding proteins and induction of type I collagen gene expression. Biochem. J. 304:1994;817-824.
15. Assoian R.K., Komoriyama A., Meyers C.A., Miller D.K., Sporn M.B. Transforming growth factor. β in human platelets J. Biol. Chem. 258:1983;7155-7160.
16. Bacon B.R., Britton R.S., O'Neill R. Effects of vitamin E deficiency on hepatic mitochondrial lipid peroxidation and oxidative metabolism in rats with chronic dietary iron overload. Hepatology. 9:1989;398-404.
17. Bacon B.R., Britton R.S. The pathology of hepatic iron overload: A free radical-mediated process. Hepatology. 11:1990;127-137.
18. Bacon, B.R., Britton, R.S., O'Neill, R., Li, S.C.Y., Kobayashi,Y. 1993. Hepatotoxicity of experimental hemochromatosis. In: Poli, G., Albano, E., Dianzani, M.U. (Eds.), Free Radicals: from Basic Science to Medicine. Birkhäuser, Basel, pp. 242-254.
19. Baer H.U., Friess H., Abou-Shady M., Berberat P., Zimmermann A., Gold L.I., Kore M., Buchler M.W. Transforming growth factor betas and their receptors in human liver cirrhosis. Eur. J. Gastroenterol. Hepatol. 10:1998;1031-1039.
20. Baeuerle P.A. The inducible transcription activator NF-kB: regulation by distinct protein subunits. Biochem. Biophys. Acta. 1072:1991;63-80.
21. Baeuerle P.A., Baltimore D. IkB: a specific inhibitor of NF-kB transcription factor. Science. 242:1988;540-546.
22. Baeuerle P.A., Henkel T. Function and activation of NF-kB in the immune system. Ann. Rev. Immunol. 12:1994;141-179.
23. Baeuerle P.A., Baltimore D. NF-kB: ten years after. Cell. 87:1996;13-20.
24. Bahadori L., Milder J., Gold L., Botney M. Active macrophage-associated TGF-. β colocalizes with type I procollagen gene expression in atherosclerotic human pulmonary arteries Am. J. Pathol. 146:1995;1228-1237.
25. Bahr M.J., Fowler A.V., Arthur M.J.P., Mann D.A. Cell type-specific regulation of the tissue inhibitor of metalloproteinases (TIMP)-1 gene promoter in hepatic stellate cells. J. Hepatol. 26(Suppl. 1):1997;66.
26. Baldwin A.S. Jr. The NF-kappa B and I kappa B proteins: new discoveries and insights. Ann. Rev. Immunol. 14:1996;649-683.
27. Balistreri W.F. Neonatal cholestasis: medical progress. J. Pediatr. 106:1985;171-184.
28. Balistreri W.F., Grand R., Hoofnagle J.H., Suchy F.J., Ryckman F.C., Perlmutter D.H., Sokol R.J. Biliary atresia: current concepts and research directions. Hepatology. 1996;23,1682-1692.
29. Ballardini G., Faccani A., Fallani M., Berti S., Vasi V., Castaldini C., Biagini G., Garbisa S., Bianchi F.B. Sequential behaviour of extracellular matrix glycoproteins in an experimental model of hepatic fibrosis. Virchows Arch. B. 49:1985;317-324.
30. Ballardini G., Groff P., Giorgi L., Schuppan D., Bianchi F.B. Ito cell heterogeneity: desmin-negative Ito cells in normal rat liver. Hepatology. 19:1994;440-446.
31. Barcellos-Hoff M.H., Derynck R., Tsang M.L-S., Weatherbee J.A. Transforming growth factor-. β activation in irradiated murine mammary gland J. Clin. Invest. 93:1994;892-899.
32. Barcellos-Hoff M.H., Dix T.A. Redox-mediated activation of latent transforming growth factor-. β 1 Mol. Endocrinol. 10:1996;1077-1083.
33. Bedossa P., Paradis V. Transforming growth factor-. β (TGF- β ) : a key role in liver fibrogenesis J. Hepatol. 22(Suppl.):1995;37-42.
34. Benyon R.C., Iredale J.P., Goddard S., Winwood P.J., Arthur M.J.P. Increased expression of tissue inhibitor of metalloproteinases-1 and -2 relative to interstitial collagenase in fibrotic human liver. Gastroenterology. 110:1996;821-831.
35. Biasi F., Chiarpotto E., Lanfranco G., Capra A., Zummo U., Chiappino I., Scavazza A., Albano E., Poli G. Oxidative stress in the development of human ischemic hepatitis during circulatory shock. Free Radic. Biol. Med. 17:1994;225-233.
36. Biasi F., Bosco M., Lanfranco G., Poli G. Cytolysis does not per se induce lipid peroxidation: evidence in man. Free Radic. Biol. Med. 18:1995;909-912.
37. Bird G.L., Sheron N., Goka A.K., Alexander G.J., Williams R.S. Increased plasma tumor necrosis factor in severe alcoholic hepatitis. Ann. Intern. Med. 112:1990;917-920.
38. Bomzon A., Holt S., Moore K. Bile acids, oxidative stress, and renal function in biliary obstruction. Semin. Nephrol. 17:1997;549-562.
39. Border W.A., Noble N.A. Transforming growth factor. β in tissue fibrosis New Engl. J. Med. 331:1994;1286-1292.
40. Bradham D.M., Igarashi A., Potter R.L., Grotendorst G.R. Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J. Cell Biol. 114:1991;1285-1294.
41. Brand K., Page S., Rogler G., Bartsch A., Brandl R., Knuechel R., Page M., Kaltschmidt C., Baeuerle P.A., Neumeier D. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J. Clin. Invest. 97:1996;1715-1722.
42. Brown P.D., Wakefield L.M., Levinson A.D., Sporn M.B. Physiochemical activation of latent transforming growth factor-beta's 1, 2 and 3. Growth Factors. 3:1990;35-43.
43. Camandola S., Scavazza A., Leonarduzzi G., Biasi F., Chiarpotto E., Azzi A., Poli G. Biogenic 4-hydroxy-2-nonenal activates transcription factor AP-1 but not NF-kB in cells of the macrophage lineage. Biofactors. 6:1997;173-179.
44. Camandola S., Aragno M.A., Cutrin J.C., Tamagno E., Danni O., Chiarpotto E., Parola M., Leonarduzzi G., Biasi F., Poli G. Liver AP-1 activation due to carbon tetrachloride is potentiated by 1,2-dibromoethane but is inhibited by. α -tocopherol or gadolinium chloride Free Radic. Biol. Med. 26:1999;1108-1116.
45. Camandola S., Poli G., Mattson M.P. The lipid peroxidation product 4-hydroxy-2,3-nonenal increases AP-1 binding activity through caspase activation in neurones. J. Neurochem. 74:2000;159-178.
46. Carini, R., Mazzanti, R., Biasi, F., Chiarpotto, E., Marmo,G., Moscarella, S., Gentilini, P., Dianzani. M.U., Poli, G. 1988. Fluorescent aldehyde protein adducts in the blood serum of healthy alcoholics. In: Normann, R., Ribiére, C., Rouach, H. (Eds.), Alcohol Toxicity and Free Radical Mechanisms. Pergamon Press, Oxford, pp. 61-64.
47. Casini A., Cunningham M., Rojkind M., Lieber C.S. Acetaldehyde increases procollagen type I and fibronectin gene transcription in cultured rat fat-storing cells through a protein synthesis-dependent mechanism. Hepatology. 13:1991;758-765.
48. Casini A., Galli G., Salzano R., Rotella C.M., Surrenti C. Acetaldehyde-protein adducts, but not lactate and pyruvate, stimulate gene transcription of collagen and fibronectin in hepatic fat-storing cells. J. Hepatol. 19:1993;385-392.
49. Castilla A., Prieto J., Fausto N. Transforming growth factors. β 1 and α in chronic liver disease: effects of interferon alpha therapy New Engl. J. Med. 324:1991;933-940.
50. Cawston T. Matrix metalloproteinases and TIMPs: properties and implications for the rheumatic diseases. Mol. Med. Today. 4:1998;130-137.
51. Chen C.C., Rosenbloom C.L., Anderson D.C., Manning A.M. Selective inhibition of E-selectin, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 expression by inhibitors of I kappa B-alpha phosphorylation. J. Immunol. 155:1995;3538-3545.
52. Chiarpotto E., Domenicotti C., Paola D., Vitali A., Nitti M.-P., Pronzato M.A., Biasi F., Cottalasso D., Marinari U.M., Dragonetti A., Cesaro P., Isidoro C., Poli G. Regulation of rat hepatocyte protein kinase C. β isoenzymes by the lipid peroxidation product 4-hydroxy-2,3-nonenal: a signaling pathway to modulate vescicular transport of glycoproteins Hepatology. 29:1999;1565-1572.
53. Clement B., Laurent M., Guguen-Guillouzo C., Lebeau G., Guillouzo A. Types I and IV procollagen gene expression in cultured rat hepatocytes. Coll. Relat. Res. 8:1988;349-359.
54. Clot P., Tabone M., Aricó S., Albano E. Monitoring oxidative damage in patients with liver cirrhosis and different daily alcohol intake. Gut. 35:1994;1637-1643.
55. Combettes L., Dumont M., Berthron B., Erlinger S., Claret M. Release of calcium from endoplasmic reticulum by bile acids in rat liver cells. J. Biol. Chem. 263:1988;2299-2303.
56. Davis G.L., Lindsay K., Albrecht J., Bodenheimer H.C. Jr., Balart L.A., Perrillo R.P., Dienstag J.L. Clinical predictor of response to recombinant Interferon-. α treatment in patients with chronic non-A non-B hepatitis (hepatitis C) J. Virol Hepatol. 1:1994;55-63.
57. Dayal S., Pati H.P., Pande G.K., Sharma M.P., Saraya A.K. Multilineage hemopoietic stem cell defects in Budd Chiari syndrome. J. Hepatol. 26:1997;293-297.
58. De Bleser P.J., Niki T., Rogiers V., Geerts A. Transforming growth factor-. β gene expression in normal and fibrotic rat liver J. Hepatol. 26:1997;886-893.
59. De Bleser P.J., Xu G., Rombouts K., Rogiers V., Geerts A. Glutathione levels discriminate between oxidative stress and transforming growth factor-beta signaling in activated rat hepatic stellate cells. J. Biol. Chem. 274:1999;33881-33887.
60. Decker K. Biologically active products of stimulated liver macrophages (Kupffer cells). Eur. J. Biochem. 192:1990;245-261.
61. De Maria N., Colantoni A., Fagiuoli S., Liu G.J., Rogers B.K., Farinati F., Van Thiel D.H., Floyd R.A. Association between reactive oxygen species and disease activity in chronic hepatitis C. Free Radic. Biol. Med. 21:1996;291-295.
62. Deugnier Y.M., Loréal O., Turlin B., Guyader D., Jouanolle H., Moirand R., Jacquelinet C., Brissot P. Liver pathology in genetic hemochromatosis: a review of 135 homozygous cases and their bioclinical correlations. Gastroenterology. 102:1992;2050-2059.
63. Dianzani M.U. 4-Hydroxynonenal and cell signalling. Free Radic. Res. 28:1998;553-560.
64. Didonato J.A., Hayakawa M., Rothwarf D.M., Zandi E., Karin M. A citokine responsive I kappa B kinase that activates the transcription factor NF-kappa B. Nature. 388:1997;548-554.
65. Dilawari, J.B., Bambery, P., Chawla, Y., Kaur, U., Bhusnurmath, S.R., Malhotra, H.S., Sood, G.H., Mitra, S.K., Khanna, S.K., Walia, B.S. 1994. Hepatic outflow obstruction (Budd-Chiari syndrome). Experience with 177 patients and a review of the literature. Medicine 73, 21-36.
66. Edwards M.J., Keller B.J., Kauffman F.C., Thurman R.G. The involvement of Kupffer cells in carbon tetrachloride toxicity. Toxicol. Appl. Pharmacol. 119:1993;275-279.
67. El-Gamel A., Sim E., Hasleton P., Hutchinson J., Yonan N., Egan J., Campbell C., Ra A., Sheldon S., Deiraniya A., Hutchinson I.V. Transforming growth factor beta (TGF-beta) and obliterative bronchiolitis following pulmonary transplantation. J. Heart Lung Transplant. 18:1999;828-837.
68. Ekström G., Ingelman-Sundberg M. Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P450. Biochem. Pharmacol. 38:1989;1313-1318.
69. + in rat liver microsomes Biochem. J. 208:1982;129-140.
70. Esterbauer H., Schaur R.J., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11:1991;81-128.
71. Farinati F., Cardin R., Maria N., Libera G., Marafin C., Lecis E., Burra P., Floreani A., Cecchetto A., Naccarato R. Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis. J. Hepatol. 22:1995;449-456.
72. Farinati F., Cardin R., Degan P., De Maria N., Floyd R.A., van Thiel D.H., Naccarato R. Oxidative DNA damage in circulating leukocytes occurs as an early event in chronic HCN infection. Free Radic. Biol. Med. 27:1990;1284-1291.
73. Fausto N. Multifunctional role for transforming growth factor. β 1 Lab. Invest. 65:1991;497-499.
74. Feinberg M.W., Jain M.K., Werner F., Sibinga N.E., Wiesel P., Wang H., Topper J.N., Perrell M.A., Lee M.E. TGF-beta1inhibits cytokine-mediated induction of MMP-12 in macrophages. J. Biol. Chem. 2000;23.
75. Flohe L., Brigelius-Flohe R., Saliou C., Traber M.G., Packer L. Redox-regulation of NF-kappa B activation. Free Radic. Biol. Med. 22:1997;1115-1126.
76. Friedman S.L. The cellular basis of hepatic fibrosis: mechanisms and treatment strategies. New Engl. J. Med. 328:1993;1828-1835.
77. Friedman S.L. Hepatic stellate cells. Prog. Liver Dis. 14:1996;101-130.
78. Friedman S.L. Cellular networks in hepatic fibrosis. Digestion. 59:1998;368-371.
79. Friedman S.L., Rockey D.C., McGuire R.F., Maher J.J., J.K, Yamasaki G. Isolated hepatic lipocytes and Kupffer cells from normal human liver: morphological and functional characteristics in primary culture. Hepatology. 15:1992;234-243.
80. Funaki M., Arii S., Monden K., Itai S., Sasaoki T., Adachi Y., Higashitsuji H., Tanaka J., Tobe T. Chemical mediators released from hepatic macrophages in primary culture: basic characteristics of human hepatic macrophages and changes in liver cirrhosis. J. Surg. Res. 54:1993;222-229.
81. Gabbiani G., Hirschel B.J., Ryan G.B., Statkov P.R., Majno G. Granulation tissue as a contractile organ: a study of structure and function. J. Exp. Med. 135:1972;719-733.
82. Garcia-Trevijano E.R., Iraburu M.J., Fontana L., Dominguez-Rosales J., Auster A., Covarrubias-Pinedo A., Rojkind M. Transforming growth factor beta1 induces the expression of alpha1 (I) procollagen mRNA by a hydrogen peroxide-C/EBPbeta-dependent mechanism in rat hepatic stellate cells. Hepatology. 29:1999;960-970.
83. Gentry L.E., Lioubin M.N., Purchio A.F., Marquardt H. Molecular events in the processing of recombinant type I pro-transforming growth factor beta to the mature polypeptide. Mol. Cell Biol. 8:1988;4162-4168.
84. Ghahary A., Shen Y.J., Scott P.G., Gong Y., Tredget E.E. Enhanced expression of mRNA for transforming growth factor-. β , type I and type III procollagen in human post-burn hypertrophic scar tissues J. Lab. Clin. Med. 122:1993;465-473.
85. Ginn-Pease, M.E., Whisler, R.L. 1998. Redox signals and NF-kB activation in T-cells.
86. Gondo K., Ueno T., Sakamoto M., Sakisaka S., Sata M., Tanikawa K. The endothelin-1 binding site in rat liver tissue: light and electron microscopic autoradiographic studies. Gastroenterology. 104:1993;1745-1749.
87. Grande J.P. Role of transforming growth factor. β in tissue injury and repair P. Soc. Exp. Biol. Med. 214:1997;27-40.
88. Greenwel P., Dominguez-Rosales J.A., Mavi G., Rivas-Estilla A.M., Rojkind M. Hydrogen peroxide: a link between acetaldehyde-elicited alpha1(I) collagen gene up-regulation and oxidative stress in mouse hepatic stellate cells. Hepatology. 31:2000;109-116.
89. Gressner A.M. Liver fibrosis: perspectives in pathobiochemical research and clinical outlook. Eur. J. Clin. Chem. Clin. Biochem. 32:1991;225-237.
90. Gressner A.M. Cytokines and cellular crosstalk involved in the activation of fat-storing cells. J. Hepatol. 22(Suppl. 2):1995;28-36.
91. Grinnell F. Fibroblasts, myofibroblasts and wound contraction. J. Cell Biol. 124:1994;401-404.
92. Haber P.S., Keogh G.W., Apte M.V., Moran C.S., Stewart N.L., Crawford D.J., Pirola R., McCaughan G.W., Ramm G.A., Wilson J.S. Activation of pancreatic stellate cells in human and experimental pancreatic fibrosis. Am. J. Pathol. 155:1999;1087-1095.
93. Hahn E.G., Wick G., Pencev D., Timpl R. Distribution of basement membrane proteins in normal and fibrotic human liver: collagen type IV laminin and fibronectin. Gut. 21:1980;63-71.
94. Halliwell B., Gutteridge J.M.C. Free Radical in Biology and Medicine. second ed. 1989;Oxford University Press, Oxford.
95. Halliwell B., Gutteridge J.M.C., Cross C.E. Free radicals, antioxidants and human disease: where are we now? J. Lab. Clin. Med. 119:1992;598-620.
96. He C., Wilhelm S.M., Pentland A.P., Marmar B.L., Grant G.A., Eise A.Z., Golberg G.I. Tissue cooperation in a proteolytic cascade activating human interstitial collagenase. Proc. Natl. Acad. Sci. USA. 86:1989;2632-2636.
97. Herbst H., Heinrichs O., Schuppan D., Milani S., Stein H. Temporal and spatial patterns of transin/stromelysin RNA expression following toxic injury in rat liver. Virchows Arch. B Cell. Pathol. 60:1991;295-300.
98. Herbst H., Wege T., Milani S., Pellegrini G., Orzechowski H.D., Bechstein W.O., Neuhaus P., Gressner A.M., Schuppan D. Tissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosis. Am. J. Pathol. 150:1997;1647-1659.
99. Higueras V., Raya A., Rodrigo J.M., Serra M.A., Romá J., Romero F.J. Interferon decreases serum lipid peroxidation products of hepatitis C patients. Free Radic. Biol. Med. 16:1994;131-133.
100. Holt K., Bennett M., Chojkier M. Acetaldehyde stimulates collagen and noncollagen protein production by human fibroblasts. Hepatology. 4:1984;843-848.
101. Houglum K., Bedossa P., Chojkier M. TGF-. β and collagen α 1(I) gene expression are increased in hepatic acinar zone I of rats with iron overload Am. J. Physiol. 30:1994;G908-G913.
102. Houglum K., Ramm G.A., Crawford D.H.G., Witztum J.L., Powell L.W., Chojkier M. Excess iron induces hepatic oxidative stress and transforming growth factor. β 1 in genetic hemochromatosis Hepatology. 26:1997;605-610.
103. Housset C.N., Rockey D.C., Bissel D.M. Endothelin receptors in rat liver: lipocytes as a contractile target for endothelin 1. Proc. Natl. Acad. Sci USA. 90:1993;9266-9270.
104. Igarashi A., Okochi H., Bradham D.M., Grotendorst G.R. Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Cell Growth Differ. 7:1993;469-480.
105. Igarashi A., Nashiro K., Kikuchi K., Sato S., Ihn H., Fujimoto M, Grotendorst G.R., Takehara K. Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders. J. Invest. Dermatol. 106:1996;729-733.
106. Ingelman-Sundberg, M. 1993. Ethanol-inducible cytochrome P450 2E1. Regulation, radical formation and toxicological importance. In: Poli, G., Albano, E., Dianzani, M.U. (Eds.), Free Radicals: from Basic Science to Medicine. Birkhäuser, Basel, pp. 287-301.
107. Iredale J.P.M., Hembry R.M., Friedman S.L., Arthur M.J.P. Human hepatic lipocytes synthesize tissue inhibitor of metalloproteinases-1 (TIMP-1): implications for regulation of matrix degradation in liver. J. Clin. Invest. 90:1992;282-287.
108. Iredale J.P., Goddard S., Murphy G., Benyon R.C., Arthur M.J.P. Tissue inhibitor of metalloproteinase-1 and interstitial collagenase expression in auto immune chronic active hepatitis and activated human hepatic lipocytes. Clin. Sci. 89:1995;75-81.
109. Iredale J.P., Benyon R.C., Arthur M.J.P., Ferris W.F., Alcolado R., Winwood P.J., Clark N., Muerphy G. Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis. Hepatology. 24:1996;176-184.
110. Irving M.G., Roll F.J., Huang S., Bissell D.M. Characterisation and culture of sinusoidal endothelium from normal liver, lipoprotein uptake and collagen phenotype. Gastroenterology. 87:1984;1233-1247.
111. Israel N., Gougerot-Pocidalo M.A., Aillet F., Virelizier J.L. Redox status of cells influences constitutive or induced NF-kappaB translocation and HIV long terminal repeat activity in human T and monocytic cell lines. J. Immunol. 149:1992;3386-3393.
112. Jain S., Furness P.N., Nicholson M.L. The role of transforming growth factor beta in chronic renal allograft nephropathy. Transplantation. 69:2000;1759-1766.
113. Jakowlew S.B., Mead J.E., Danielpour D., Wu J., Roberts A.B., Fausto N. Transforming growth factor isoforms in rat liver regeneration: messenger RNA expression and activation of latent TGF-beta. Cell Regulation. 2:1991;535-548.
114. Jarnagin W.R., Rockey D.C., Koteliansky V.E., Wang S.S., Bissell D.M. Expression of variant fibronectins in wound healing: cellular sources and biological activity of the EIIIA segment in rat hepatic fibrogenesis. J. Cell Biol. 127:1994;2037-2048.
115. Kamimura S., Gaal K., Britton R.S., Bacon B.R., Triadafilopolous G., Tsukamoto H. Increased 4-hydroxynonenal levels in experimental alcoholic liver disease: association of lipid peroxidation with liver fibrogenesis. Hepatology. 16:1992;448-453.
116. Kanashiro C.A., Khalil R.A. Signal transduction by protein kinase C in mammalian cells. Clin. Exp. Pharmacol. Physiol. 25:1998;974-985.
117. Kanzaki T., Olofsson A., Moren A., Wernstedt C., Hellman U., Miyazono K., Claesson-Welsh L., Heldin C.H. TGF-beta 1 binding protein: a component of the large latent complex of TGF-beta 1 with multiple repeat sequences. Cell. 61:2000;1051-1061.
118. Kim S.J., Dehnez F., Kim K.Y., Holt J.T., Sporn M.B., Roberts A.B. Activation of the second promoter of the transforming growth factor-. β 1 gene by transforming growth factor- β 1 and phorbol ester occurs through the same target sequences J. Biol. Chem . 264:1989;19373-19378.
119. Knecht K.T., Bradfort B.U., Mason R.P., Thurman R.G. In vivo formation of free radical metabolite of ethanol. Mol. Pharmacol. 38:1990;26-30.
120. Kovacs E.J. Fibrogenic cytokines: the role of immune mediators in the development of scar tissue. Immunol. Today. 12:1991;17-23.
121. Krähenbühl S., Talos C., Fischer S., Reichen J. Toxicity of bile acids on the electron transport chain of isolated rat liver mitochondria. Hepatology. 19:1994;471-479.
122. Kulkarni, A.B., Karlsson, S. 1993. Transforming growth factor beta-1 knockout mice. A mutation in one cytokine gene causes a dramatic inflammatory disease. Am. J. Pathol. 143, 3-9.
123. Kunkel S.L., Chensue S.W., Phan S.H. Prostaglandins as endogenous mediators of interleukin-1 production. J. Immunol. 136:1986;186-192.
124. Lalazar A., Wong L., Yamasaki G., Friedman S.L. Early genes induced in hepatic stellate cells during wound healing. Gene. 195:1997;235-243.
125. Lamireau T., Bail B., Boussarie L., Fabre M., Vergnes P., Bernard O., Gautier F., Bioulac-Sage P., Rosenbaum J. Expression of collagens types I and IV, osteonectin and transforming growth factor beta-1 (TGFbeta1) in biliary atresia and paucity of intrahepatic bile ducts during infancy. J. Hepatol. 31:1999;248-255.
126. Larrea E., Garcia N., Qian C., Civeira M.P., Prieto J. Tumor necrosis factor alpha gene expression and the response to interferon in chronic hepatitis C. Hepatology. 23:1996;210-217.
127. Lee W., Mitchell P., Tjian R. Purified transcription factor AP-1 interacts with TPA inducible enhancer elements. Cell. 49:1987;741-752.
128. Lefkowitch J.H., Mendez L. Morphologic features of hepatic injury in cardiac disease and shock. J. Hepatol. 2:1986;313-327.
129. Lee K.S., Buck M., Houglum K., Chojkier M. Activation of hepatic stellate cells by. TGFα and collagen type I is mediated by oxidative stress through c-myb expression J. Clin. Invest. 96:1995;2461-2468.
130. Lee T.Y., Chin G.S., Kim W.J., Chau D., Gittes G.K., Longaker M.T. Expression of transforming growth factor beta1,2, and 3 proteins in keloids. Ann. Plast. Surg. 43:1999;179-184.
131. Leonarduzzi G., Parola M., Muzio G., Garramone A., Maggiora M., Robino G., Poli G., Dianzani M.U., Canuto R.A. Hepatocellular metabolism of 4-hydroxy-2,3-nonenal is impaired in conditions of chronic cholestasis. Biochem. Biophys. Res. Commun. 214:1995;669-675.
132. Leonarduzzi G., Scavazza A., Biasi F., Chiarpotto E., Camandola S., Vogl S., Dargel R., Poli G. The lipid peroxidation end-product 4-hydroxy-2,3-nonenal up-regulates transforming growth factor. β 1 expression in the macrophage lineage: a link between oxidative injury and fibrosclerosis FASEB J. 11:1997;851-857.
133. Leonarduzzi G., Arkan M.C., Basaga H., Chiarpotto E., Sevanian A., Poli G. Lipid oxidation products in cell signaling. Free Radic. Biol. Med. 28:2000;1370-1378.
134. Lindros K.O. Zonation of cytochrome P450 expression, drug metabolism and toxicity in liver. Gen. Pharmacol. 28:1997;191-196.
135. Liu W., Akhand A.A., Kato M., Yokoyama I., Miyata T., Kurokawa K., Uchida K., Nakashima I. 4-Hydroxynonenal triggers an epidermal growth factor receptor-linked signal pathway for growth inhibition. J. Cell Sci. 112:1999;2409-2417.
136. Lo Y.Y., Cruz T.F. Involvement of reactive oxygen species in cytokine and growth factor induction of c-fos expression in chondrocytes. J. Biol. Chem. 270:1995;11727-11730.
137. Lubrano R., Frediani T., Citti G., Cardi E., Mannarino O., Elli M., Cozzi F. Erythocyte membrane lipid peroxidation before and after vitamin E supplementation in children with cholestasis. J. Pediatr. 115:1989;380-384.
138. Lyons R.M., Keski-Oja J., Moses H.L. Proteolytic activation of latent transforming growth factor-. β from fibroblast conditioned medium J. Cell Biol. 106:1988;1659-1665.
139. Lyons R.M., Gentry L.E., Purchio A.F., Moses H.L. Mechanisms of activation of latent recombinant transforming growth factor. β 1 by plasmin J. Cell Biol. 110:1990;1361-1367.
140. MacKichan M.L., Logeat F., Israel A. Phosphorylation of p105 PSET sequence via a redox-insensitive pathway up-regulates processing of p50 NF-kappaB. J. Biol. Chem. 271:1996;6084-6091.
141. Maher J.J., Bissell D.M., Friedman S.L., Roll F.J. Collagen measured in primary cultures of normal rat hepatocytes derives from lipocytes within the monolayer. J. Clin. Invest. 82:1988;450-459.
142. Maher J.J., Tzagarakis C., Gimenez A. Malondialdehyde stimulates collagen production by hepatic lypocytes only upon activation in primary culture. Alcohol and Alcoholism. 29:1994;605-610.
143. Marok R., Winyard P.G., Coumbe A., Kus M.L., Gaffney K., Blades S., Mapp P.I., Morris C.J., Blake D.R., Kaltschmidt C., Baeuerle P.A. Activation of the transcription factor nuclear factor kappaB in human inflamed synovial tissue. Arthritis Rheum. 39:1996;583-591.
144. Martin M., Lefaix J., Delanian S. TGF-beta1 and radiation fibrosis: a master switch and a specific therapeutic target? Int. J. Radiation. Oncol. Biol. Phys. 47:2000;277-290.
145. Marra F., Pinzani M., De Franco R., Laffi G., Gentilini P. Involvement of phosphatidyl-inositol 3-kinase in the activation of the extracellular signal-regulated kinase by PDGF in hepatic stellate cells. FEBS Lett. 376:1995;141-145.
146. Marra F., Choudhury G., Abboud H.E. Interferon. γ -mediated activation of STAT1 α regulates growth factor-induced mitogenesis J. Clin. Invest. 98:1996;1218-1230.
147. Marra F., Gentilini A., Pinzani M., Choudhury G.G., Parola M., Herbst H., Dianzani M.U., Laffi G., Abboud H.E., Gentilini P. Phosphatidyl-inositol 3-kinase is required for platelet-derived growth factors actions on hepatic stellate cells. Gastroenterology. 112:1997;1297-1306.
148. Marra F., De Franco R., Grappone C., Parola M., Milan S., Leonarduzzi G., Pastacaldi S., Wenzel U.O., Pinzani M., Dianzani M.U., Laffi G., Gentilini P. Expression of monocyte chemotactic protein 1 precedes monocyte recruitment in a rat model of acute liver injury: modulation by vitamin E pretreatment. J. Invest. Med. 47:1999;66-75.
149. Martinez-Hernandez A. The hepatic extracellular matrix. I. Electron immunohistochemical studies in normal rat liver. Lab. Invest. 51:1984;57-69.
150. Maruyama K., Feinman L., Fainsilber Z., Nakano M., Okazaki I., Lieber C.S. Mammalian collagenase increases in early alcoholic liver disease and decreases with cirrhosis. Life Sci. 30:1982;1379-1384.
151. Massagué J. The transforming growth factor beta family. Annu. Rev. Cell Biol. 6:1990;597-641.
152. Massagué J. TGFβ signaling: receptors, transducers, and MAD proteins Cell. 85:1996;947-950.
153. Mazzanti R., Srai K.S., Debnam E.S., Boss A.M., Gentilini P. The effect of chronic ethanol consumption on iron absorption in rats. Alcohol and Alcoholism. 22:1987;47-52.
154. McClain C.J., Cohen D.A. Increased tumor necrosis factor production by monocytes in alcoholic hepatitis. Hepatology. 9:1989;349-351.
155. 2 and antioxidants have opposite effects on activation of NF-kB and AP-1 in intact cells: AP-1 as secondary antioxidant responsive factor EMBO J. 12:1993;2005-2015.
156. Milani S., Herbst H., Schuppan D., Kim K.Y., Hahan E.G., Stein H. In situ hybridization for procollagen types I, III, and IV mRNA in normal and fibrotic rat liver: evidence for predominant expression in non-parenchymal liver cells. Hepatology. 10:1989;84-92.
157. Milani S., Herbst H., Schuppan D., Riecken E.O., Stein H. Cellular localization of types I, III, and IV procollagen gene transcripts in normal and fibrotic human liver. Am. J. Pathol. 137:1990;59-70.
158. Milani S., Herbst H., Schuppan D., Surrenti C. Transforming growth factors-. β 1 and - β 2 are differentially expressed in fibrotic liver disease Am. J. Pathol. 139:1991;1221-1229.
159. Milani S., Herbst H., Schuppan D., Grappone S.C., Pellegrini G., Pinzani M., Casini A., Calabro A., Ciancio G., Stefanini F., Burroughs A.K., Surrenti C. Differential expression of metalloproteinase-1 and -2 genes in normal and fibrotic human liver. Am. J. Pathol. 144:1994;528-537.
160. Milani S., Herbst H., Schuppan D., Grappone C., Heinrichs O.E. Cellular sources of extracellular matrix proteins in normal and fibrotic liver. Studies of gene expression by in situ hybridization. J. Hepatol. 22(Suppl. 2):1995;71-76.
161. Miyamoto S., Verma I.M. Rel/NF-kappa B/Ikappa B story. Adv. Cancer Res. 66:1995;255-292.
162. Miyazono K., Yuki K., Takaku F., Wernstedt C., Kanzaki T., Olofsson A., Hellman U., Heldin C.-H. Latent forms of TGF beta: structure and biology. Piez K.A., Sporn M.B. Transforming Growth Factors Beta: Chemistry Biology and Therapeutics. 1990;52-58 New York Academy of Sciences, New York.
163. Miyazono K., Ichijo H., Heldin C.H. Transforming growth factor-. β latent forms binding proteins and receptors Growth Factors. 8:1993;11-22.
164. Morimoto M., Hagbjörk A.-L., Wan Y.J.Y., Fu P.C., Clot P., Ingelman-Sundberg M., Albano E., French S.W. Modulation of alcoholic liver disease by cytochrome P450 2E1 inhibitors. Hepatology. 21:1995;610-617.
165. Murawaki Y., Nishimura Y., Ikuta Y., Idobe Y., Kitamura Y., Kawasaki H. Plasma transforming growth factor-beta 1 concentrations in patients with chronic viral hepatitis. J. Gastroenterol. Hepatol. 13:1998;680-684.
166. Muto Y., Nouri-Aria K.T., Meager A., Alexander J.A., Eddleston A.L., Williams R. Enhanced tumor necrosis factor and interleukin in fulminant hepatic failure. Lancet. 9:1998;72-74.
167. Myers B.M., Prendergast F.G., Holman R., Kuntz S.M., Larusso N.F. Alterations in hepatocyte lysosomes in experimental hepatic copper overload in rats. Gastroenterology. 105:1993;1814-1823.
168. Nakatsukasa H., Nagy P., Evarts R.P., Hsia C., Marsden E., Thorgeirsson S. Cellular distribution of transforming growth factor-. β 1 and procollagen Types I, III, IV transcripts in carbon tetrachloride-induced liver fibrosis J. Clin. Invest. 5:1990a;1833-1843.
169. Nakatsukasa H., Evarts R.P., Hsia C., Thorgeirsson S. Transforming growth factor-. β 1 and type I procollagen transcripts during regeneration and early fibrosis in rat liver Lab. Invest. 73:1990b;171-180.
170. Niemela, O, Parkkila, S., Britton, R.S., Ramm, G.A., ONeill, R., Janney, C.G., Brunt, E.M., Bacon, B.R. 1995. Hepatic lipid peroxidation in patients with ereditary hemochromatosis. Hepatology 22, 372A (Abstr).
171. Niemela O., Parkkila S., Britton R.S., Brunt E.M., Janney C.G., Bacon B.R. Hepatic lipid peroxidation in hereditary hemochromatosis and alcoholic liver injury. J. Lab. Clin. Med. 133:1999;451-460.
172. 4 -induced fibrotic rat livers Hepatology. 23:1996;1538-1545.
173. Nikol S., Isner J.M., Pickering J.G., Kearney M., Leclerc G., Wier L. Expression of transforming growth factor-. β 1 is increased in human vascular restenosis lesions J. Clin. Invest. 90:1992;1582-1592.
174. Nolan G., Baltimore D. The inhibitory ankyrin and activator Rel proteins. Curr. Opin. Genet. Dev. 2:1992;211-220.
175. Ohhira M., Ohtake T., Matsumoto A., Saito H., Ikuta K., Fujimoto Y., Ono M., Toyokuni S., Kohgo Y. Immunohistochemical detection of 4-hydroxy-2-nonenal-modified-protein adducts in alcoholic liver diseases. Alcohol Clin. Exp. Res. 22(3 Suppl.):1998;11145S-11149S.
176. Okazaki, I., Maruyama, K. 1974. Collagenase activity in experimental hepatic fibrosis. Nature (London) 252, 49-50.
177. Okazaki, I., Watanabe, T., Hozawa, S., Arai, M., Maruyama, K. 2000. Molecular mechanism of the reversibility of hepatic fibrosis: with special reference to the role of matrix metalloproteinases. J. Gastroenterol. Hepatol. 15 (Suppl.), D26-D32.
178. Olaso E., Friedman S.L. Molecular regulation of hepatic fibrogenesis. J. Hepatol. 29:1998;836-847.
179. Olson E.M., Sternberg E., Hu J.S., Spizz G., Wilcox C. Regulation of myogenic differentiation by type beta transforming growth factor. J. Cell Biol. 103:2000;1799-1805.
180. Park C.H., Bacon B.R., Brittenham G.M., Tavill A.S. Pathology of dietary carbonyl iron overload in rats. Lab. Invest. 57:1987;555-563.
181. Parola M., Muraca R., Dianzani I., Barrera G., Leonarduzzi G., Bendinelli P., Piccoletti R., Poli G. Vitamin E dietary supplementation inhibits transforming growth factor. β 1 gene expression in the rat liver FEBS Lett. 308:1992;267-270.
182. Parola M., Pinzani M., Casini A., Albano E., Poli G., Gentilini A., Gentilini P., Dianzani M.U. Stimulation of lipid peroxidation or 4-hydroxynonenal treatment increase procollagen alpha (I) gene expression and synthesis in human liver fat storing cells. Biochem. Biophys. Res. Commun. 194:1993;1044-1050.
183. Parola M., Leonarduzzi G., Robino G., Albano E., Poli G., Dianzani M.U. On the role of lipid peroxidation in the pathogenesis of liver damage induced by long standing cholestasis. Free Radic. Biol. Med. 20:1996;351-359.
184. Parola M., Robino G., Marra F., Pinzani M., Bellomo G., Leonarduzzi G., Chiarugi G., Camandola S., Poli G., Waeg G., Gentilini P., Dianzani M.U. HNE interacts directly with JNK isoforms in human hepatic stellate cells. J. Clin. Invest. 102:1998;1942-1950.
185. Parola M., Robino G., Dianzani M.U. 4-Hydroxy-2,3-alkenals as molecular mediators of oxidative stress in the pathogenesis of liver fibrosis. Int. J. Mol. Med. 4:1999;425-432.
186. Paradis V., Kollinger M., Fabre M., Holstege A., Poynard T., Bedossa P. In situ detection of lipid peroxidationby-products in chronic liver diseases. Hepatology. 26:1997;135-142.
187. Paradis V., Darere D., Vidaud M., Gouville A.-C., Huet S., Martinez V., Gauthier J.-M., Ba N., Sobesky R., Ratziu V., Bedossa P. Expression of connective tissue growth factor in experimental rat and human liver fibrosis. Hepatology. 30:1999;968-976.
188. Peters S.W., Jones B.M., Jacobs A., Wagstaff M. Free iron and lipid peroxidation in the plasma of patients with iron overload. Spik G., Montreuil J., Chricton R.R., Mazurier J. Proteins of Iron Storage and Transport. 1985;321-324 Elsevier, New York.
189. Pietrangelo A. Iron, oxidative stress and liver fibrogenesis. J. Hepatol. 28:1998;8-13.
190. Pietrangelo A., Rocchi E., Schiaffonati L., Ventura E., Cairo G. Liver gene expression during chronic dietary overload in rats. Hepatology. 11:1990;798-804.
191. Pietrangelo A., Gualdi R., Casalgrandi G., Montosi G., Ventura E. Molecular and cellular aspects of iron-induced hepatic cirrhosis in rodents. J. Clin. Invest. 95:1995a;1824-1831.
192. Pietrangelo A., Borella F., Casalgrandi G., Montosi G., Ceccarelli D., Gallesi D., Giovannini F., Gasparetto A., Masini A. Antioxidant activity of sylibin in vivo during chronic iron overload in rats. Gastroenterology. 109:1995b;1941-1949.
193. Pinzani M. Novel insight into the biology and physiology of the Ito cell. Pharmacol. Ther. 66:1995;387-412.
194. Pinzani M., Gesualdo L., Sabbah G.M., Abboud H.E. Effects of platelet-derived growth factor, and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat storing cells. J. Clin. Invest. 84:1989;1786-1793.
195. Pinzani M., Gentilini A., Caligiuri A., De Franco R., Pellegrini G., Milani S., Marra F., Gentilini P. Transforming growth factor-. β 1 regulates platelet-derived growth factor β subunit in human liver fat-storing cells Hepatology. 21:1995;232-239.
196. Pinzani M., Milani S., Franco R., Grappone C., Caligiuri A., Gentilini A., Tosti-Guerra C., Maggi M., Failli P., Ruocco C., Gentilini P. Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells. Gastroenterology. 110:1996;534-548.
197. Pinzani M., Marra F., Carloni V. Signal transduction in hepatic stellate cells. Liver. 18:1998;2-13.
198. Pircher R., Jullien P., Lawrence D.A. Beta transforming growth factor is stored in human blood platelets as a latent high molecular weight complex. Biochem. Biophys. Res. Commun. 136:1986;30-37.
199. Poli G., Parola M. Oxidative damage and fibrogenesis. Free Radic. Biol. Med. 22:1997;287-305.
200. Poli G., Biasi F., Chiarpotto E., Dianzani M.U., De Luca A., Esterbauer H. Lipid peroxidation in human diseases: evidence of red cell oxidative stress after circulatory shock. Free Radic. Biol. Med. 6:1989;167-170.
201. Poli G., Dianzani M.U., Cheeseman K.H., Slater T.F., Lang J., Esterbauer H. Separation and characterization of the aldehydic products of lipid peroxidation stimulated by carbon tetrachloride or ADP-iron in isolated rat hepatocytes and rat liver microsomal suspensions. Biochem. J. 227:1985;629-638.
202. Rahmsdorf H.J. Modulation of Fos and Jun in response to adverse environmental agents. Angel P.E., Herrlich P.E. The Fos and Jun Families of Transcription Factors. 1994;169-189 CRC Press, Boca Raton.
203. Ramm, G.A., Britton, R.S., O'Neill, R., Blaner, W.S., Bacon, B.R. 1995. Vitamin A poor lypocytes: a novel desmin-negative lypocyte subpopulation, which can be activated to myofibroblasts. Am. J. Physiol. 269 (Pt 1), G532-G541.
204. Ramm G.A., Nair V.G., Bridle K.R., Shepherd R.W., Crawford D.H.G. Contribution of hepatic parenchymal and nonparenchymal cells to hepatic fibrogenesis in biliary atresia. Am. J. Pathol. 153:1998;527-535.
205. Ramadori, G., Rieder, H., Knittel, T., Dienes, H.P., Meyer zum Buschenfelde, K.-H., 1987. Fat storing cells (FSC) of rat liver synthesize and secrete fibronectin. Comparison with hepatocytes. J. Hepatol. 4, 190-197.
206. Ramadori G., Knittel T., Saile B. Fibrosis and altered matrix synthesis. Digestion. 59:1998;372-375.
207. Riley P.A. Free radicals in biology: oxidative stress and the effects of ionizing radiation. Int. J. Radiat. Biol. 65:1994;27-33.
208. Roberts A.B., Sporn M.B. Physiological actions and clinical applications of transforming growth factor. β Growth Factors. 8:1993;1-9.
209. Roberts A.B., Heine U.I., Flanders K.C., Sporn M.B. Transforming growth factor. β : a major role in regulation of extracellular matrix Ann. NY Acad. Sci. 580:1990;225-232.
210. Roeb E., Graeve L., Hoffman R., Decker K., Edwards D.R., Heinrich P.C. Regulation of tissue inhibitor of metalloproteinases-1 gene expression by cytokines and dexamethasone in rat hepatocyte primary cultures. Hepatology. 18:1993;1437-1442.
211. Roeb E., Rosejohn S., Erren A., Edwards D.R., Matern S., Graeve L., Heinrich P.C. Tissue inhibitor of metalloproteinases-2 (TIMP-2) in rat liver cells is increased by lipopolysaccharide and prostaglandin E(2). FEBS Lett. 357:1995;33-36.
212. Roulot D., Sevcsik A.-M., Coste T., Strosberg A.D., Marullo S. Role of transforming growth factor. β type II receptor in hepatic fibrosis: studies of human chronic hepatitis C and experimental fibrosis in rats Hepatology. 29:1999;1730-1738.
213. Roth-Eichhorn S., Kühl K., Gressner A.M. Subcellular localization of (latent) transforming growth factor. β and the latent TGF- β binding protein in rat hepatocytes and hepatic stellate cells Hepatology. 28:1998;1588-1596.
214. Ruef J., Rao G.N., Li F., Bode C., Patterson C., Bhatnagar A., Runge M.S. Induction of rat aortic smooth muscle cell growth by the lipid peroxidation product 4-hydroxy-2-nonenal. Circulation. 97:1998;1071-1078.
215. Rupec R.A., Baeuerle P.A. The genomic response of tumor cells to hypoxia and reoxygenation. Differential activation of transcription factors AP-1 and NF-kB. Eur. J. Biochem. 234:1995;632-640.
216. Scholmerich J., Becher M.S., Schmidt K., Schubert R., Kremer B., Feldhouse S., Gerok W. Influence of hydroxylation and conjugation of bile acids on their membrane-damaging properties: studies on isolated hepatocytes and membrane vesicles. Hepatology. 4:1984;661-666.
217. Schreck R., Rieber P., Baeuerle P.A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J. 10:1991;2247-2258.
218. Schreck R., Meier B., Männel D., Dröge W., Baeuerle P.A. Dithiocarbamates as potent inhibitors of NF-kB activation in intact cells. J. Exp. Med. 175:1992;1181-1194.
219. Schreck R., Albermann K., Baeuerle P.A. Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Radic. Res. Commun. 17:1992b;221-237.
220. Schull M.M., Ormsby I., Kier A.B., Pawlowski S., Diebold R.J., Yin M., Allen R., Sidman C., Proetzel G., Calvin D., Annunziata N., Doetschman T. Targeted disruption of the mouse transforming growth factor. β 1 gene results in multifocal inflammatory disease Nature. 359:1992;693-699.
221. Schultz-Cherry S., Murphy-Ullrich J.E. Role for carbohydrate structures in TGF-. β 1, latency Nature. 338:1993;158-160.
222. Schuppan D. Structure of extracellular matrix in normal and fibrotic liver: collagens and glycoproteins. Semin. Liver Dis. 10:1990;1-10.
223. Sen C.K., Packer L. Antioxidant and redox regulation of gene transcription. FASEB J. 10:1996;709-720.
224. Simon M., Bourel L., Genetet B., Fauchet R. Demonstration of recessive transmission and early detection by family HLA typing. New Engl. J. Med. 297:1977;1017-11022.
225. Sokol R.J., Devereaux M., Khandwala R.A. Effect of dietary lipid and vitamin E on mitochondrial lipid peroxidation and hepatic injury in the bile duct-ligated rats. J. Lipid Res. 32:1991;1349-1357.
226. Sokol R.J., Devereaux M., O'Brien K., Khandwala R.A., Loehr J.P. Abnormal hepatic mitochondrial respiration and cytochrome c oxidase activity in rats with long-term copper overload. Gastroenterology. 105:1993;178-187.
227. Sokol, R.J., Twedt, D., McKim, J.M. Jr, Devereaux, M., Karrer, F.M., Kam, I., von Steigman, G., Narkewicz, M.R., Bacon, B.R., Britton, R.S., Neuschwander-Tetri, B.A., 1994. Oxidant injury to hepatic mitochondria in patients with Wilson's disease and Bedlington terriers with copper toxicosis. Gastroenterology 107, 1778-1798.
228. Sokol R.J., Devereaux M., Khandwala R.A., O'Brien K. Evidence for involvement of oxygen free radicals in bile acid toxicity to isolated rat hepatocytes. Hepatology. 17:1995;869-881.
229. Spivey J.R., Bronk S.F., Gores G.J. Glycochenodehoxycholate-induced letal hepatocellular injury in rat hepatocytes. Role of ATP depletion and cytosolic free calcium. J. Clin. Invest. 92:1993;17-24.
230. Stal P., Broome U., Sheynius A., Befrits R., Hultcrantz R. Kupffer cell iron overload induces intercellular adhesion molecule-1 expression on hepatocytes in genetic hemochromatosis. Hepatology. 21:1995;1308-1316.
231. Sternlieb I. Perspectives on Wilson's disease. Hepatology. 12:1990;1234-1239.
232. Suc I., Meilhac O., Lajoie-Mazenc I., Vanfaele J., Jurgens G., Salvayre R., Negre-Salvayre A. Activation of EGF receptor by oxidized LDL. FASEB J. 12:1998;665-671.
233. Suematsu M., Oda M., Suzuki H., Kaneko H., Watanabe N., Furusho T., Masushige S., Tsuchiya M. Intravital and electronmicroscopic observation of Ito cells in rat hepatic microcirculation. Microvascular Res. 46:1993;28-42.
234. Suzuki Y.J., Packer L. Inhibition of NF-kappa B activation by vitamin E derivatives. Biochem. Biophys. Res. Commun. 193:1993;277-283.
235. Suzuki Y.J., Aggarwal B.B., Packer L. Alpha-lipoic acid is a potent inhibitor of NF-kappa B activation in human T cells. Biochem. Biophys. Res. Commun. 189:1992;1709-1715.
236. Suzuki Y.J., Mizuno M., Packer L. Transient over expression of catalase does not inhibit TNF- or PMA-induced NF-kappa B activation. Biochem. Biophys. Res. Commun. 210:1995;537-541.
237. Svegliati Baroni G., D'Ambrosio L., Ferretti G., Casini A., Di Sario A., Salzano R., Ridolfi F., Saccomanno S., Jezequel A.M., Benedetti A. Fibrogenic effect of oxidative stress on rat hepatic stellate cells. Hepatology. 27:1998;720-726.
238. 2 -induced stimulation of mitogen-activated protein kinases (extracellular-signal-regulated kinase and c-Jun NH2-terminal kinase) Eur. J. Biochem. 244:1997;587-595.
239. Tsukamoto H. Activation of fat storing cells in alcoholic liver fibrosis: role of Kupffer cells and lipid peroxidation. Surrenti C., Casini A., Milani S., Pinzani M. Fat Storing Cell and Liver Fibrosis. 1994;189-195 Kluwer Academic Publisher, Lancaster.
240. Tsukamoto H., Horne W., Kamimura S., Niemela O., Parkkila S., Yla-Herttuala S., Brittenham G.M. Experimental liver cirrhosis induced by alcohol and iron. J. Clin. Invest. 96:1995;620-630.
241. Uchida K., Shiraishi M., Naito Y., Torii Y., Nakamura Y., Osawa T. Activation of stress signaling pathways by the end product of lipid peroxidation. 4-Hydroxy-2-nonenal is a potential inducer of intracellular peroxide production. J. Biol. Chem. 274:1999;2234-2242.
242. Valius M., Kazlaukas A. Phospholipase C-gamma and phosphatidylinositol 3-kinase are the downstream mediators of the PDGF receptor's mitogenic signal. Cell. 73:1993;321-324.
243. Vyas S.K., Leyland H., Gentry J., Arthur M.J.P. Transin (stromelysin) is expressed in early rat lipocyte primary culture. Gastroenterology. 109:1995;889-898.
244. Yamamoto T., Nakamura T., Noble N.A., Ruoslahti E., Border W.A. Expression of transforming growth factor. β is elevated in human and experimental diabetic nephropathy Proc. Natl. Acad. Sci. U.S.A. 90:1993;1814-1818.
245. Yoshioka K., Takemura T., Murakami K., Okada M., Hino S., Miyamoto H., Maki S. Transforming growth factor-. β protein and mRNA in glomeruli in normal and diseased human kidneys Lab. Invest. 68:1993;154-163.
246. Yokota R., Fukai M., Shimamura T., Suzuki T., Watanabe Y., Nagashima K., Kishida A., Furukawa H., Hayashi T., Todo S. A novel hydroxyl radical scavenger, nicaraven, protects the liver from warm ischemia and reperfusion injury. Surgery. 127:2000;661-669.
247. Young I.S., Trouton T.G., Torney J.J., McMaster D., Callender M.E., Trimble E.R. Antioxidant status and lipid peroxidation in hereditary haemocromatosis. Free Radic. Biol. Med. 16:1994;393-397.
248. Yura T., Fukunaga M., Khan R., Nassar G.N., Badr K.F., Montero A. Free-radical-generated F2-isoprostane stimulates cell proliferation and endothelin-1 expression on endothelial cells. Kidney Int. 56:1999;471-478.
249. Winwood P.J., Schuppan D., Iredale J.P., Kawser C.A., Docherty A.J.P., Arthur M.J.P. Kupffer cell-derived 95-kDa type IV collagenase/gelatinase B: characterization and expression in cultured cells. Hepatology. 22:1995;304-315.
250. Wojnarowski C., Frischer T., Hofbauer E., Grabner C., Mosgoeller W., Eichler I., Ziesche R. Cytokine expression in bronchial biopsies of cystic fibrosis patients without acute exacerbation. Eur. Respir. J. 14:1999;1136-1144.
251. Wrana J.L. Transforming growth factor-. β signaling and cirrhosis Hepatology. 29:1999;1909-1910.
252. 2+ -activated nuclear protease in rat liver following carbon tetrachloride administration Biochem. Biophys. Res. Commun. 197:1993;585-590.